Ankrin Therapeutics

Ankrin Therapeutics is a biotech start-up developing first-in-class drugs for cancer treatment. Our novel and unique therapeutic strategies, founded on forefront high quality research in cancer biology, target essential protein-protein interactions required for error-free DNA damage repair.

Contact name:

Rafel Simó Vicens (Project Coordinator)

Address:

Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark

Number of employees:

5

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2019 DANISH BIO – DANSK BIOTEK. All rights reserved.